Last reviewed · How we verify
IODOHIPPURATE
IODOHIPPURATE is a drug. It is currently FDA-approved (first approved 1982).
Iodohippurate is a small molecule used in medical research, specifically studied in conditions such as Acute Kidney Injury, Chronic Kidney Disease, and Hypertension. It is used in interventions such as 24 hour ambulatory Blood Pressure monitoring and Peripheral Arterial Tonometry, as seen in clinical trials.
At a glance
| Generic name | IODOHIPPURATE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Key clinical trials
- Severe Sepsis in Children - IMPRESS-C
- Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IODOHIPPURATE CI brief — competitive landscape report
- IODOHIPPURATE updates RSS · CI watch RSS
Frequently asked questions about IODOHIPPURATE
What is IODOHIPPURATE?
When was IODOHIPPURATE approved?
What development phase is IODOHIPPURATE in?
Related
- Therapeutic area: All drugs in Nephrology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing